The global Enzyme Replacement Therapy (ERT) market is poised for significant expansion, projected to reach USD 21.62 billion ...

SHANGHAI, CHINA / ACCESS Newswire / July 22, 2025 / Lingyi Biotech , a clinical-stage biotechnology company specializing in ...

Treatment with ambroxol for symptoms of Parkinson’s disease dementia was safe, but its efficacy was undetermined in a small ...

Over 70 million Indians live with rare diseases, facing challenges like delayed diagnosis, high treatment costs, and limited ...

The sector is expected to hit $553.8m by 2034. The growing integration of genetic testing into national healthcare frameworks ...

A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a neurologist explains the connection.

Discover how early diagnosis and enzyme replacement therapy helped Prajwal overcome Gauchers disease and shine in cricket ...

Researchers believe the HPgV virus could be an environmental trigger or contributor to Parkinson's disease.

Gaucher disease, a rare disorder, is caused by inherited deficiency of the enzyme glucocerebrosidase. It is unique among the ultra-orphan disorders in that four treatments are currently approved by ...

Seahawks Round-Up: Seahawks Mailbag, Mike Macdonald's Fathers Battle With Kidney Disease, His Ask And More All the Seahawks news you might have missed from this week.